EZR and melanoma: Knowing that ezrin is involved in the regulation of the actin cytoskeleton organisation, we analysed the expression levels of total ezrin and phospho-ezrin (T567) in vemurafenib-sensitive and vemurafenib-resistant A375 melanoma cells harbouring the BRAFV600E mutation under the baseline culture conditions and after exposure to 0.8 μM vemurafenib (corresponding to the IC50 concentration of vemurafenib measured in sensitive melanoma cells) for 72 h (Figure 6).